A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation
Korean Journal of Hepatology 2014³â 20±Ç 3È£ p.306 ~ p.309
ÀÌÀ±¼®(Lee Yoon-Serk) - Konkuk University School of Medicine Department of Internal Medicine
±èÁ¤ÇÑ(Kim Jeong-Han) - Konkuk University School of Medicine Department of Internal Medicine
À±Çü¿µ(Yoon Hyeon-Young) - Konkuk University School of Medicine Department of Internal Medicine
ÃÖ¿øÇõ(Choe Won-Hyeok) - Konkuk University School of Medicine Department of Internal Medicine
±Ç¼Ò¿µ(Kwon So-Young) - Konkuk University School of Medicine Department of Internal Medicine
ÀÌâȫ(Lee Chang-Hong) - Konkuk University School of Medicine Department of Internal Medicine
Abstract
Radio-frequency ablation (RFA) is a curative treatment for hepatocellular carcinoma (HCC). Percutaneous RFA has been shown to be beneficial for patients with small renal cell carcinoma (RCC) lacking indications for resection. We experienced the case of a 53-year-old male who had conditions that suggested HCC, RCC, and alcoholic liver cirrhosis. Abdominal contrast-enhanced computed tomography (CT) and magnetic resonance image showed liver cirrhosis with 2.8 cm ill-defined mass in segment 2 of the liver and 1.9 cm hypervascular mass in the left kidney. These findings were compatible with the double primary cancers of HCC and RCC. Transarterial chemoembolization (TACE) was performed to treat the HCC. After the TACE, a focal lipiodol uptake defect was noticed on a follow up CT images and loco-regional treatment was recommended. Therefore, we performed RFAs to treat HCC and RCC. There was no evidence of recurrence in the follow up image after 1 month.
Å°¿öµå
Hepatocellular carcinoma, Renal cell carcinoma, Radiofrequency ablation
KMID :
1103920140200030306
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)